15.84USD-2.13%Mkt Cap: 164.04M USDP/E: —Last update: 2026-06-01
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of …
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap164.04M USD
Enterprise Value212.97M USD
Revenue (TTM)96.10M USD
Gross Profit71.78M USD
Net Income (TTM)-35.27M USD
Revenue/Share11.80 USD
Last Price15.84 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees334
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-74.18
PEG—
EV/EBITDA-10.82
EV/Revenue2.22
P/S1.76
P/B18.05
EPS (TTM)-3.96
EPS (Forward)-0.22
52W Range
5.00071% of range20.21
52W High20.21 USD
52W Low5.000 USD
Profitability
Gross Margin81.11%
Oper. Margin-25.81%
EBITDA Margin-20.47%
Profit Margin-39.85%
ROE1430.63%
ROA-40.31%
Growth
Revenue Growth42.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.27M USD
CapEx (TTM)403.00K USD
FCF Margin-14.34%
FCF Yield-8.40%
Net Debt48.00M USD
Net Debt/EBITDA-2.44
Balance Sheet
Debt/Equity-29.56
Current Ratio2.82
Quick Ratio2.42
Book Value/Sh0.9040 USD
Cash/Share2.530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 15, 2025
Analyst Consensus
Rating—
Target (Mean)30.50 USD
Target Range22.00 USD – 40.00 USD
# Analysts4
Ownership
Shares Out.10.36M
Float5.34M
Insiders43.16%
Institutions38.63%
Short Interest
Short Ratio1.7d
Short % Float2.43%
Short % Out.1.36%
Shares Short137.20K
Short (prev mo.)174.02K
Technical
SMA 5013.81 (+14.7%)
SMA 20010.28 (+54.1%)
Beta0.42
S&P 52W Chg27.94%
Avg Vol (30d)68.85K
Avg Vol (10d)39.74K
Technical Indicators
RSI (14)62.9
MACD0.5666
MACD Signal0.4296
MACD Hist.+0.1370
BB Upper17.27 USD
BB Middle14.61 USD
BB Lower11.95 USD
BB Width36.37%
ATR (14)1.136 USD
Vol Ratio (20d)1.24x